LMR Partners’s Forte Biosciences FBRX Stock Holding History

LMR Partners’s Portfolio FBRX Stock Details FBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-262	Closed	-$224K	–	1194
2021 Q1	$224K	Buy	+262	New	+$215K	0.01%	780

Other funds holding FBRX

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

LMR Partners's FBRX Position: Q2 2021 in Review

LMR Partners sold out of Forte Biosciences (FBRX) in Q2 2021, closing a stake of 262 shares — an estimated $224K sold.

LMR Partners first reported a position in FBRX in Q1 2021 and held it in 1 quarter. The position peaked at $224K in Q1 2021. 75 funds tracked by Wall St. Rank hold FBRX as of Q2 2021.

LMR Partners reported no remaining Forte Biosciences position as of Q2 2021 after selling out during the quarter.
LMR Partners sold 262 Forte Biosciences shares in Q2 2021, an estimated $224K.
LMR Partners first reported a position in Forte Biosciences in Q1 2021 and held it in 1 quarter.
LMR Partners's Forte Biosciences position peaked at $224K in Q1 2021.
75 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2021.

Based on LMR Partners's 13F filing for Q2 2021, filed 16 Aug 2021.